# A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants

> **NCT06348888** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 30 (actual)

## Conditions studied

- Advanced Non-small Cell Lung Cancer
- EGFR Mutation
- HER2 Mutation
- Healthy Volunteers

## Interventions

- **DRUG:** BAY2927088
- **DRUG:** Itraconazole
- **DRUG:** Carbamazepine

## Key facts

- **NCT ID:** NCT06348888
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-10
- **Primary completion:** 2024-06-12
- **Final completion:** 2024-06-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06348888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06348888, "A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06348888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*